Suven Life Sciences announced that it has received one product patent from India and one product patent from South Africa corresponding to the New Chemical Entities (NCEs). This will be used for the treatment of disorders associated with Neurodegenerative diseases. The granted patents are valid through 2028 and 2032 respectively. <a title="Suven Share Price" href="https://www.dynamiclevels.com/en/suven-share-pric